CD123 Blood Tumor Package | Lahalak Platform
An advanced diagnostic package to differentiate between complex blood and immune system tumors, helping accurately identify the tumor type to choose the latest targeted therapies suitable for your condition.
Scientific name: Immunohistochemistry: CD123 Diagnostic Package
This diagnostic package, based on immunohistochemistry, involves testing for a range of markers to diagnose and differentiate proliferative tumors of the bone marrow, blood, and lymph nodes. The package primarily includes testing for CD123 (interleukin-3-alpha receptor, a marker for plasmacytoid dendritic cells), along with essential complementary...
Service type
Immunohistochemistry (IHC) Diagnostic Package
Duration
20-30 minutes
Fasting
Fasting is not required
Included Services
- Comprehensive examination of the core immunological marker set for classifying blood tumors (CD123, CD34, CD117).
- Testing for a complementary lymphoid marker (CD20 or CD3) to help differentiate between strains.
- Consultation for interpretation of the overall results with a pathologist specializing in blood diseases and hematopoietic tumors.
- Personal support services from Lahalak
Medical Service Information
Conditions & Notices
- It requires the submission of a whole tissue block (paraffin block) from the biopsy specimen (from bone marrow, lymph node, skin, or other organ) or slices from a bone marrow smear.
- It is necessary to attach the initial pathology report, the results of the complete blood count (CBC) and the results of the flow cytometry, if available.
- The patient does not need to fast, as the sample is tissue or bone marrow.
- Due to the complexity of the differential diagnosis, the completion time may range from 7 to 14 working days.
Medical services you might also like
